Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers

Huffman, KE; Li, LS; Carstens, R; Park, H; Girard, L; Avila, K; Wei, SG; Kollipara, R; Timmons, B; Sudderth, J; Bendris, N; Kim, J; Villalobos, P; Fujimoto, J; Schmid, S; Deberardinis, RJ; Wistuba, I; Heymach, J; Kittler, R; Akbay, EA; Posner, B; Wang, YZ; Lam, S; Kliewer, SA; Mangelsdorf, DJ; Minna, JD

Huffman, KE (通讯作者)，Univ Texas Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dept Internal Med, Dallas, TX 75390 USA.;Huffman, KE (通讯作者)，Univ Texas Southwestern Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.

FRONTIERS IN ONCOLOGY, 2023; 13 ():

Abstract

The glucocorticoid receptor (GR) is an important anti-cancer target in lymphoid cancers but has been understudied in solid tumors like lung cancer, al......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索